Stock Analysis

Spotlight On December 2024's Leading Growth Companies With Insider Ownership

In a global market characterized by mixed performances, with major U.S. stock indexes reaching record highs and growth stocks outpacing value shares by significant margins, investors are increasingly focusing on companies with strong growth potential and substantial insider ownership. Such companies often align management's interests with those of shareholders, a crucial factor for success in today's volatile economic environment.

Advertisement

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
SKS Technologies Group (ASX:SKS)27.9%24.8%
Archean Chemical Industries (NSEI:ACI)22.9%41.3%
Propel Holdings (TSX:PRL)36.9%37.6%
On Holding (NYSE:ONON)19.1%29.4%
Pharma Mar (BME:PHM)11.8%56.2%
CD Projekt (WSE:CDR)29.7%27%
Plenti Group (ASX:PLT)12.8%120.1%
EHang Holdings (NasdaqGM:EH)32.8%81.5%
Elliptic Laboratories (OB:ELABS)26.8%111.4%
Findi (ASX:FND)34.8%112.9%

Click here to see the full list of 1513 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Guangdong Zhongsheng Pharmaceutical (SZSE:002317)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Guangdong Zhongsheng Pharmaceutical Co., Ltd. operates in the pharmaceutical industry and has a market capitalization of approximately CN¥11.06 billion.

Operations: Guangdong Zhongsheng Pharmaceutical Co., Ltd. does not have specific revenue segments listed in the provided text.

Insider Ownership: 27.8%

Earnings Growth Forecast: 41.7% p.a.

Guangdong Zhongsheng Pharmaceutical shows potential for growth with earnings forecasted to grow significantly at 41.7% annually, outpacing the broader Chinese market's 25.9%. However, recent financial performance indicates a decline, with net income dropping to CNY 148.8 million from CNY 279.5 million year-over-year as of September 2024. Revenue growth is expected at 16.3%, slower than desired for high-growth companies, and profit margins have decreased from last year’s figures, posing challenges amidst insider ownership stability.

SZSE:002317 Ownership Breakdown as at Dec 2024
SZSE:002317 Ownership Breakdown as at Dec 2024

Sinofibers TechnologyLtd (SZSE:300777)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sinofibers Technology Co., Ltd. specializes in the research, development, production, and sales of high-performance carbon fibers and fabrics, with a market capitalization of CN¥12.14 billion.

Operations: The company generates revenue through its involvement in the research, development, production, and sales of advanced carbon fibers and fabrics.

Insider Ownership: 12.5%

Earnings Growth Forecast: 25.2% p.a.

Sinofibers Technology Ltd. demonstrates growth potential with revenue forecasted to increase by 22.6% annually, surpassing the Chinese market's average of 13.8%. Despite this, earnings growth at 25.2% is slightly below market expectations of 25.9%, and profit margins have decreased significantly from last year’s figures of 76.8% to 39.8%. Recent financials show increased sales but a slight decline in net income, alongside stable insider ownership and a completed share buyback worth CNY 8.22 million.

SZSE:300777 Earnings and Revenue Growth as at Dec 2024
SZSE:300777 Earnings and Revenue Growth as at Dec 2024

Plus Alpha ConsultingLtd (TSE:4071)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Plus Alpha Consulting Co., Ltd. offers marketing solutions and has a market capitalization of ¥78.95 billion.

Operations: The company generates revenue through its HR Solutions segment, contributing ¥10.13 billion, and Marketing Solutions segment, contributing ¥3.78 billion.

Insider Ownership: 39.4%

Earnings Growth Forecast: 17.4% p.a.

Plus Alpha Consulting Ltd. is positioned for growth with earnings forecasted to rise by 17.4% annually, outpacing the JP market's average of 7.9%. Despite a volatile share price, it trades at a significant discount to its estimated fair value. The company has announced a share repurchase program worth ¥3 billion and increased dividends, reflecting efforts to enhance shareholder returns and capital efficiency while maintaining stable insider ownership levels.

TSE:4071 Ownership Breakdown as at Dec 2024
TSE:4071 Ownership Breakdown as at Dec 2024

Make It Happen

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SZSE:002317

Guangdong Zhongsheng Pharmaceutical

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Flawless balance sheet unattractive dividend payer.

Advertisement

Weekly Picks

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8227.1% undervalued
11 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
WO
BMBL logo
woodworthfund on Bumble ·

Swiped Left by Wall Street: The BMBL Rebound Trade

Fair Value:US$960.0% undervalued
3 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ·

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6433.4% undervalued
15 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

BA
NVO logo
bactrian on Novo Nordisk ·

A Quality Compounder Marked Down on Overblown Fears

Fair Value:US$9540.8% undervalued
95 users have followed this narrative
8 users have commented on this narrative
1 users have liked this narrative
YI
ETSY logo
yiannisz on Etsy ·

Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces

Fair Value:US$64.454.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ALGN logo
yiannisz on Align Technology ·

Align Technology Stock: Premium Orthodontics in a Cost-Sensitive World

Fair Value:US$154.628.4% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
69 users have followed this narrative
10 users have commented on this narrative
20 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25429.4% overvalued
71 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.0% undervalued
1020 users have followed this narrative
6 users have commented on this narrative
28 users have liked this narrative